propyphenazone has been researched along with Diabetes Mellitus, Type 2 in 1 studies
propyphenazone: structure
propyphenazone : A pyrazolone derivative that is antipyrine substituted at C-4 by an isopropyl group.
Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Terzioğlu, K | 1 |
| Ediger, D | 1 |
| Tülümen Öztürk, R | 1 |
| Durmuş, E | 1 |
| Alışır, MF | 1 |
1 other study available for propyphenazone and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Kounis syndrome not induced but prevented by the implantation of a drug-eluting stent: a case report.
Topics: Acetaminophen; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antipyrine; Diabetes Mellitus, Type 2; | 2017 |